首页 | 本学科首页   官方微博 | 高级检索  
     

辛伐他汀对大鼠肾缺血再灌注损伤后心肌Bcl-2和Bax蛋白表达的影响
引用本文:荆娇,马海玲,闫文升,张永忠,张玉清,焦宗伟. 辛伐他汀对大鼠肾缺血再灌注损伤后心肌Bcl-2和Bax蛋白表达的影响[J]. 中国病理生理杂志, 2017, 33(12): 2274-2277. DOI: 10.3969/j.issn.1000-4718.2017.12.026
作者姓名:荆娇  马海玲  闫文升  张永忠  张玉清  焦宗伟
作者单位:石家庄医学高等专科学校, 河北 石家庄 050000
基金项目:河北省教育厅高等学校科学技术指导性研究项目(No.Z2014020)
摘    要:目的:观察辛伐他汀对肾缺血再灌注损伤后心肌组织的影响及其机制。方法:随机将36只大鼠分为假手术组、肾缺血再灌注组和辛伐他汀组,每组12只。后2组用夹闭双侧肾动脉的方法复制肾缺血再灌注损伤模型;辛伐他汀组在造模前给予辛伐他汀(20 mg·kg~(-1)·d~(-1))灌胃,持续2周。用生化检查检测血清肌酐(SCr)、血尿素氮(BUN)、心肌组织丙二醛(MDA)含量及乳酸脱氢酶(LDH)、肌酸激酶(CK)和超氧化物歧化酶(SOD)的活性,并用Western blot法检测Bcl-2和Bax的表达水平。结果:与假手术组比,缺血再灌注组SCr、BUN和心肌MDA含量均升高(P0.05),心肌LDH和CK活性增强(P0.05),心肌SOD活性明显下降(P0.05);与缺血再灌注组比较,辛伐他汀组SCr、BUN和心肌MDA的含量降低(P0.05),心肌LDH和CK活性明显减弱(P0.05),而心肌SOD活性增强(P0.05)。与假手术组比较,心肌Bcl-2与Bax的蛋白表达水平在肾缺血再灌注组增多(P0.05);与缺血组相比,Bax表达在辛伐他汀组明显降低,而Bcl-2表达增加(P0.05)。结论:辛伐他汀对肾缺血再灌注后的心肌有保护作用,保护机制可能与辛伐他汀可以消除自由基、升高Bcl-2蛋白表达和降低Bax蛋白表达有一定关系。

关 键 词:辛伐他汀  肾缺血再灌注损伤  心肌  丙二醛  超氧化物歧化酶  乳酸脱氢酶  
收稿时间:2017-05-10

Effects of simvastatin on expression of Bcl-2 and Bax in myocardium of rats with renal ischemia-reperfusion injury
JING Jiao,MA Hai-ling,YAN Wen-sheng,ZHANG Yong-zhong,ZHANG Yu-qing,JIAO Zong-wei. Effects of simvastatin on expression of Bcl-2 and Bax in myocardium of rats with renal ischemia-reperfusion injury[J]. Chinese Journal of Pathophysiology, 2017, 33(12): 2274-2277. DOI: 10.3969/j.issn.1000-4718.2017.12.026
Authors:JING Jiao  MA Hai-ling  YAN Wen-sheng  ZHANG Yong-zhong  ZHANG Yu-qing  JIAO Zong-wei
Affiliation:Shijiazhuang Medical College, Shijiazhuang 050000, China
Abstract:AIM: To observe the effect of simvastatin on myocardial tissue after renal ischemia-reperfusion injury and its mechanism. METHODS: A rat model of renal ischemia-reperfusion injury was prepared by clamping the bilateral renal arteries for 45 min. The rats (n=36) were randomly divided into sham operation group, renal ischemia-reperfusion (I/R) group and simvastatin group with 12 rats in each group. The content of serum creatinine (SCr), blood urea nitrogen (BUN) and myocardial tissue malondialdehyde (MDA), the myocardial activity of lactate dehydrogenase (LDH), creatine kinase (CK) and superoxide dismutase (SOD), and the myocardial protein expression of Bcl-2 and Bax were detected. RESULTS: Compared with sham operation group, the content of SCr, BUN and myocardial MDA, and the myocardial activity of LDH and CK in I/R group were significantly increased (P<0.05), and the activity of SOD was significantly decreased (P<0.05). Compared with I/R group, the content of SCr, BUN and myocardial MDA, and the myocardial activity of LDH and CK in simvastatin group were significantly decreased (P<0.05), while SOD activity was enhanced (P<0.05). The protein expression of Bcl-2 and Bax in sham operation group was less than that in I/R group (P<0.05), and the protein level of Bax in simvastatin group was significantly lower than that in I/R group (P<0.05), while the protein level of Bcl-2 was increased (P<0.05). CONCLUSION: Simvastatin has a protective effect on the myocardium of the rats with renal ischemia-reperfusion injury, and the protective mechanism may be related to the elimination of free radicals by simvastatin, increase in the protein expression of Bcl-2 and decrease in the protein expression of Bax.
Keywords:Simvastatin  Renal ischemia-reperfusion injury  Myocardium  Malondialdehyde  Superoxide dismutase  Lactate dehydrogenase
本文献已被 CNKI 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号